This prospective study included 135 patients (median age, 67 years; 66 women) who underwent MRI-guided SBRT for liver metastases across seven international centres between April 2019 and April 2023.
MIRAGE phase III randomized controlled trial shows a significant reduction in GU and GI toxicities with MRIdian® MRI-guided versus CT-guided SBRT More notably, there were improvements in multiple ...
The use of magnetic resonance–guided daily adaptive stereotactic body radiotherapy (SBRT) for patients with prostate cancer reduces the risk of acute urinary side effects of grade 2 or higher by 44% ...
Final outcomes comparing acute grade ≥2 genitourinary toxicity following MRI- vs. CT-guided prostate SBRT presented at ASTRO 2022 Final outcomes of the phase III randomized trial comparing acute grade ...
Magnetic resonance imaging (MRI) is indispensable for clinical diagnostics and treatment planning, offering unparalleled soft tissue contrast. However, intrinsic imperfections—stemming from gradient ...
Local ablative therapy, such as radiotherapy or surgery, plays a key role in treatment of patients with oligometastatic disease. Stereotactic ablative body radiotherapy (SABR) comes to the fore as a ...
In the section "Summary of Relevant Literature," paragraph 6, sentence 1, the reference 15, after "Japan" was incorrect. Reference 15 was given as "Yoon SM, Lim YS, Park MJ, et al: Stereotactic body ...
Rachel works as a CRNA where she provides anesthesia care across the lifespan, including pediatric anesthesia, with a primary focus on orthopedic anesthesia. She is also an Assistant Professor at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results